gmi 2018.png
Continuous Renal Replacement Therapy Market to exceed $1.3 billion by 2024: Global Market Insights, Inc.
November 19, 2018 06:00 ET | Global Market Insights, Inc
Sellbyville, Delaware, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Global Continuous Renal Replacement Therapy Market will surpass USD 1.3 billion by 2024; according to a new research report by Global...
Picture1.jpg
CHF Solutions, Inc. to Present at the LD Micro 10th Annual Main Event on December 5, 2017
November 30, 2017 07:15 ET | CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Nov. 30, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that Claudia Drayton, Chief Financial Officer will be a featured presenter at the LD Micro...
Picture1.jpg
CHF Solutions’ Aquadex FlexFlow® Aquapheresis System Receives FDA IDE Approval for Clinical Study for Pediatric Use
June 29, 2017 07:00 ET | CHF Solutions
EDEN PRAIRIE, Minn., June 29, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc., (fka Sunshine Heart, Inc.) (NASDAQ:CHFS) announced today that researchers in the Stanford University School of Medicine’s...
Picture1.jpg
CHF Solutions’ Aquadex Flexflow® Ultrafiltration System Featured in the May 2017 Journal of The American College of Cardiology Review of Ultrafiltration as a Promising Treatment for Fluid Overload Associated with Heart Failure
June 05, 2017 07:00 ET | CHF Solutions
EDEN PRAIRIE, Minn., June 05, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc., (fka Sunshine Heart, Inc.) (NASDAQ:CHFS) announced today that clinical trials using its Aquadex FlexFlow® Ultrafiltration...
American Heart Association Logo
Ultrafiltration May Not be Best Approach for Heart Failure Patients
November 06, 2012 20:13 ET | American Heart Association
Study Highlights: Ultrafiltration, which removes excess fluid from the body, was no better than an aggressive diuretic-based approach in reducing congestion in heart failure...